Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Suppression of Immune Response by ‘Vincristine’ and ‘Vinblastine’

Abstract

CHEMICAL suppression of immunological responsiveness has been achieved in recent years by several classes of compounds. In particular, the alkalating agents1, the antipurines2 and the folic acid antagonists3 have been effective chemicals. However, since none of these drugs has offered complete suppression under conditions of clinical trial, the discovery of new classes of chemicals which inhibit immune reactions remains an important objective. The double indole-indoline alkaloids4 ‘Vincristine’ (vincristine sulphate) and ‘Vinblastine’ (vincaleukoblastine sulphate) were isolated from the common periwinkle plant Vinca rosea by two groups of investigators working independently5,6. Since these compounds have been effective growth inhibitors of a variety of lymphoid neoplasms7–9, it appeared worth while to investigate their effects on immune responses. This communication reports inhibition of antibody formation and delayed hypersensitivity to bovine serum albumin in rats following administration of the two drugs.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Hektoen, L., and Corper, H. J., J. Infect. Dis., 28, 279 (1921).

    Article  Google Scholar 

  2. Schwartz, R., Eisner, A., and Dameshek, W., J. Clin. Invest., 38, 1394 (1959).

    Article  CAS  Google Scholar 

  3. Upsoff, D. E., Proc. Soc. Exp. Biol. Med., 99, 651 (1958).

    Article  Google Scholar 

  4. Neuss, N., Gorman, M., Boaz, H. E., and Conc, N. J., J. Amer. Chem. Soc., 84, 1509 (1962).

    Article  CAS  Google Scholar 

  5. Johnson, I. S., Wright, H. F., Svoboda, G. H., and Vlantis, J., Cancer Res., 20, 1016 (1960).

    CAS  PubMed  Google Scholar 

  6. Noble, R. L., Beer, C. T., and Cutts, J. H., Ann. N.Y. Acad. Sci., 76, 882 (1958).

    Article  ADS  CAS  Google Scholar 

  7. Hodes, M. E., Rohn, R. J., and Bond, W. H., Cancer Res., 20, 1041 (1960).

    CAS  PubMed  Google Scholar 

  8. Warwick, O. H., Alison, R. E., and Darte, J. M., Canad. Med. Assoc. J., 85, 579 (1961).

    CAS  PubMed  Google Scholar 

  9. Armstrong, J. G., Dyke, R. W., Fouts, P. J., and Gahimer, J. E., Cancer Chemotherapy Rep., No. 18, 49 (1962).

  10. Janković, B. D., Waksman, B. H., and Arnason, B. G., J. Exp. Med., 116, 159 (1962).

    Article  Google Scholar 

  11. Arnason, B. G., Janković, B. D., Waksman, B. H., and Wennersten, C., J. Exp. Med., 116, 177 (1962).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

AISENBERG, A. Suppression of Immune Response by ‘Vincristine’ and ‘Vinblastine’. Nature 200, 484 (1963). https://doi.org/10.1038/200484a0

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/200484a0

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing